In seven samples, the histological and immunphenotypic data favoured the diagnosis of CCPRCC; however, the presence of the VHL gene promoter hypermethylation abnormality leads us to place these samples into the CCRCC group. This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.